SCHEMBL29634701

SCHEMBL29634701

N#Cc1cc2c(cn1)OC1(CCNCC1)C2

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 2/20 0.33
▸ CHEK1 O14757 1/20 0.31
▸ CHEK2 O96017 1/20 0.31
▸ HDAC3 O15379 2/20 0.31
▸ HDAC4 P56524 2/20 0.31
▸ HDAC1 Q13547 2/20 0.31
▸ HDAC7 Q8WUI4 2/20 0.31
▸ HDAC2 Q92769 2/20 0.31
▸ HDAC10 Q969S8 2/20 0.31
▸ HDAC11 Q96DB2 2/20 0.31
▸ HDAC8 Q9BY41 2/20 0.31
▸ HDAC6 Q9UBN7 2/20 0.31
▸ HDAC9 Q9UKV0 2/20 0.31
▸ HDAC5 Q9UQL6 2/20 0.31
▸ GABRP O00591 1/20 0.30
▸ GABRD O14764 1/20 0.30
▸ GABRA1 P14867 1/20 0.30
▸ GABRB1 P18505 1/20 0.30
▸ GABRG2 P18507 1/20 0.30
▸ GABRB3 P28472 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24408808 1.00 IRAK4 (0.33) IRAK4CHEK1CHEK2HDAC3HDAC4
SCHEMBL29634720 0.78 IRAK4 (0.34) IRAK4HDAC3HDAC4HDAC1HDAC7
SCHEMBL24408905 0.78 IRAK4 (0.34) IRAK4HDAC3HDAC4HDAC1HDAC7
SCHEMBL24408815 0.78 IRAK4 (0.34) IRAK4HDAC3HDAC4HDAC1HDAC7
SCHEMBL29634725 0.77 KDM4E (0.34) IRAK4HDAC3HDAC4HDAC1HDAC7
SCHEMBL22582992 0.75 IRAK4 (0.38) IRAK4GABRPGABRDGABRA1GABRB1
SCHEMBL24409148 0.72 OPRD1 (0.35) IRAK4HDAC3HDAC4HDAC1HDAC7
SCHEMBL28753038 0.71 GPR119 (0.47) —
SCHEMBL863433 0.71 OPRD1 (0.43) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL23811371 0.69 CHRNB2 (0.43) IRAK4HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022095971-A1 SPIRO HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 上海医药集团股份有限公司 2022-05-12 — — WO disclosed
Send feedback